Research Into the OX40 Molecule is Opening Potential New Avenues in Atopic Dermatitis Research

Through our collaboration with Amgen, we are gaining valuable insights into the role OX40 may play in the #atopicdermatitis inflammatory response.

Learn more about the importance of OX40 from Emma Guttman, Health System Chair of the Department of Dermatology at Icahn School of Medicine at Mount Sinai.



Recruitment
Fraud Alert

Contact Us

*Required

Contact Form

  • For questions related to our products, please use the links provided under Our Medicines.

By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, services, and disease-state information and/or utilize your information for market research or analytics. Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute your personal information outside the above terms of consent.

Are you visiting this site from Canada? If so, consider visiting our Canadian site. It's designed to bring you up-to-date content.

 

Click "Leave Page" to visit the Kyowa Kirin Canada site.

Or click “OK” to stay on the Kyowa Kirin US site.

Option to close the window